Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Aβ25-35-induced Alzheimer’s disease by inhibiting the phosphorylation of IκBα and p38

References

• Frisoni GB, Boccardi M, Barkhof F, et al. Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers. Lancet Neurol. 2017;16(8):661–676.
   PubMed Web of Science ®Google Scholar
• Chambers DJ, Sebastian J, Ahearn DJ. Parkinson’s disease. BJA Educ. 2017;17(4):145–149.
   Web of Science ®Google Scholar
• Snowden JS. The Neuropsychology of Huntington’s Disease. Arch Clin Neuropsychol. 2017;32(7):876–887.
   PubMed Web of Science ®Google Scholar
• Falk I, Jacobson S. Multiple sclerosis. Neuroimmune Pharmacol. 2017;355–364. DOI:10.1056/NEJM200.j009283431307
   Google Scholar
• Niu H, Álvarez-Álvarez I, Guillén-Grima F, et al. Prevalence and incidence of Alzheimer’s disease in Europe: a meta-analysis. Neurologia. 2017;32(8):523–532.
   PubMed Web of Science ®Google Scholar
• Bagyinszky E, Giau VV, Shim K, et al. Role of inflammatory molecules in the Alzheimer’s disease progression and diagnosis. J Neurol Sci. 2017;376:242–254.
   PubMed Web of Science ®Google Scholar
• Kliushnik TP, Androsova LV, Mikhaylova NM, et al. Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer’s disease. Neurosci Behav Physiol. 2019;49(3):352–356.
   Google Scholar
• Kim MS, Kim Y, Choi H. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model. Gut. 2019;69(2):gutjnl-2018-317431.
   Web of Science ®Google Scholar
• Raikwar SP, Thangavel R, Dubova I, et al. Targeted gene editing of Glia maturation factor in Microglia: a novel Alzheimer’s disease therapeutic target. Mol Neurobiol. 2019;56(1):378–393.
   PubMed Web of Science ®Google Scholar
• Nesi G, Sestito S, Digiacomo M, et al. Oxidative stress, mitochondrial abnormalities and proteins deposition: multitarget approaches in Alzheimer’s disease. Curr Top Med Chem. 2017;17(27):3062–3079.
   PubMed Web of Science ®Google Scholar
• Flemmig J, Zámocký M, Alia A. Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease. Neural Regen Res. 2018;13(7):1170.
   PubMed Web of Science ®Google Scholar
• Kamphuis W, Kooijman L, Schetters S. Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer’ s disease. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2016;1862(10):1847–1860.
   PubMed Web of Science ®Google Scholar
• Wang LJ, Qiao ZD, Liang DL, et al. Gx-50 reduces β-amyloid-induced TNF-α, IL-1β, NO and PGE2 expression and inhibits NF- κB signaling in a mouse model of Alzheimer’s disease. Eur J Immunol. 2016;197(2):665–676.
   Google Scholar
• Liu N, Zhuang Y, Zhou Z, et al. NF-κB dependent up-regulation of TRPC6 by Aβ in BV-2 microglia cells increases COX-2 expression and contributes to hippocampus neuron damage. Neurosci Lett. 2017;651:1–8.
   PubMed Web of Science ®Google Scholar
• Bu X, Fan J, Hu X, et al. Norwegian scabies in a patient treated with Tripterygium glycoside for rheumatoid arthritis. An.bras.dermatol. 2017;92(4):556–558.
   PubMed Web of Science ®Google Scholar
• Lian F, Wang Y, Xu H, et al. Chinese experience with tripterygium wilfordii multiglycoside as long-term maintenance therapy in lupus nephritis. Ann Rheum Dis. 2013;71(Suppl3):675.2–675.
   Google Scholar
• Liu JH, Li Y, Huang LY, et al. Effects of insulin on intervention therapy of Tripterygium Polyglycoside combine with Nicotinamide in LADA patients. Chin J Mod Med. 2005;15:145–147.
   Google Scholar
• Zhang X, Xia J, Ye H. Effect of Tripterygium polyglycoside on interleukin-6 in patients with Guillain-Barre syndrome. Zhongguo Zhong XI Yi Jie He Za Zhi. 2000;20(5):332–334.
   PubMedGoogle Scholar
• Jiang Q, Tang XP, Chen XC. Will Chinese externaltherapy with compound Tripterygium wilfordii hook F gel safely con-trol disease activity in patients with rheumatoidarthritis: design of adouble-blinded randomized controlled trial. BMC Complement Altern Med. 2017;17(1):444.
   PubMedGoogle Scholar
• Wang M, Chen TG, Yang XL. Effect of tripterygium glycosides on inflammatory factors induced by lipopolysaccharide in rat astrocytes. Chinese J Clin Pharmacol. 2019;35(2):154–158.
   Google Scholar
• Zheng JH, Zhong JH, Cao HJ, et al. Tripterygium glycosides suppress colitis via NOXs-ROS-NLRP3 inflammatory signaling pathways. Chinese J Pathophysiol. 2016;32(9):1653–1659.
   Google Scholar
• Wang S, Li R, He S. Tripterygii Radix et Rhizoma glycosides upregulate the new anti-inflammatory cytokine IL-37 through ERK1/2 and p38 MAPK signal pathways. Evid Based Complement Alternat Med. 2017;5:9148523. DOI:10.1155/2017/9148523
   PubMedGoogle Scholar
• Shan P, Lu Z, Ye L. Effect of Tripterygii Radix et Rhizoma polyglycoside on experimental prostatitis caused byureaplasma urealyticum in rats. Med Sci Monit. 2016;22:3722–3726.
   PubMed Web of Science ®Google Scholar
• Choi SY, Lee J, Lee DG. Sanghyun Lee. Acer okamotoanumimproves cognition and memory function in Aβ25-35-induced Alzheimer’ s mice model. Appl Biol Chem. 2017;60(1):1–9.
   Web of Science ®Google Scholar
• Nie Q. Effects of triptolide on the BF-KB expression of the microglial cells and the apoptosis of Hippocampal neurons in the cellular model of AD. Nanchang Uni. 2010;1:1–156.
   Google Scholar
• Zheng WG, Zhou F, Gao L, et al. Baicalein reduces Aβ-induced PC12 cell damage by inhibiting the JAK2/STAT1 pathway. Acta Pharma Sin. 2021;56(3):771–777.
   Google Scholar
• Wang M, Chen TG, Yang LX, et al. Effect of tripterygium glycosides on inflammatory factors induced by lipopolysaccharide in rat astrocytes. Chin J Clin Pharmacol. 2019;35(2):154–156.
   Google Scholar
• Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature Protocol. 2006;1(2):848–858.
   PubMed Web of Science ®Google Scholar
• Tang L, Liu L, Li GY, et al. Expression Profiles of Long non-coding RNAs in Intranasal LPS-mediated Alzheimer’s disease model in mice. Biomed Res Int. 2019;9642589. DOI:10.1155/2019/9642589.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang Y, Tang L, et al. The neuroprotective effect of Byu d Mar 25 in LPS-Induced Alzheimer’s disease mice model. Evid Based Complement Alternat Med. 2021;(2021)(5):1–12.
   Google Scholar
• Stephenson J, Nutma E, Valk PVD, et al. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154(2):204–219.
   PubMed Web of Science ®Google Scholar
• Ju Hwang C, Choi DY, Park MH, et al. NF-kB as a mediator of brain inflammation in AD. CNS Neurol Disord Drug Targets. 2019;18(1):3–10.
   PubMed Web of Science ®Google Scholar
• Kllstig E, Mccabe BD, Schneider BL. The links between als and nf-κb. Int J Mol Sci. 2021;22(8):3875.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang L, Yu X. The role of microglia in Alzheimer’s disease. Guocheng Gongcheng Xuebao/Chin J Process Eng. 2018;18(5):900–907.
   Google Scholar
• Prins JR, Eskandar S, Bjl E, et al. Microglia, the missing link in maternal immune activation and fetal neurodevelopment; and a possible link in preeclampsia and disturbed neurodevelopment? J Reprod Immunol. 2018;126:18.
   PubMed Web of Science ®Google Scholar
• Li JJ, Liu SJ, Liu XY, et al. Herbal compounds with special reference to gastrodin as potential therapeutic agents for microglia mediated neuroinflammation. Curr Med Chem. 2018;25(42):5958–5974.
   PubMed Web of Science ®Google Scholar
• Wang JY, Lee CT, Wang JY. Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia. Neuroscience. 2014;281(281):164–177.
   PubMedGoogle Scholar
• Costas-Insua C, Merino-Gracia J, Aicart-Ramos C, et al. Subcellular targeting of nitric oxide synthases mediated by their N-Terminal Motifs. Adv Protein Chem Struct Biol. 2018;111:165–195.
   PubMed Web of Science ®Google Scholar
• Chen H, Xu Y, Wang J, et al. Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation and oxidative stress in rat. Int J Clin Exp Pathol. 2015;8(9):10139–10147.
   PubMed Web of Science ®Google Scholar
• Ding X, Wang D, Li L, et al. Dehydroepiandrosterone ameliorates H2O2-induced Leydig cells oxidation damage and apoptosis through inhibition of ROS production and activation of PI3K/Akt pathways. Int J Biochem Biotechnol. 2016;70:126–139.
   Google Scholar
• Ji W, Li H, Gao F, et al. Effects of Tripterygium glycosides on interleukin-17 and CD4+CD25+CD127low regulatory T-cell expression in the peripheral blood of patients with ankylosing spondylitis. Biomed Rep. 2014;2(4):517–520.
   PubMedGoogle Scholar
• Ren J, Wu X, Liao N, et al. Prevention of postoperative recurrence of Crohn’s disease: Tripterygii Radix et Rhizoma polyglycoside versus mesalazine. J Int Med Res. 2013;41(1):176–187.
   PubMed Web of Science ®Google Scholar
• Matta R, Wang X, Ge H, et al. Triptolide induces anti-inflammatory cellular responses. Am J Transl Res. 2009;1(3):267–282.
   PubMed Web of Science ®Google Scholar
• Ma ZJ, Zhang XN, Li L, et al. Tripterygium glycosides tablet ameliorates renal tubulointerstitial fibrosis via the toll-like receptor 4/nuclear factor Kappa B signaling pathway in high-fat diet fed and streptozotocin-induced diabetic rats. J Diabetes Res. 2015;(2015):1–10.
   Web of Science ®Google Scholar
• Facci L, Barbierato M, Skaper SD. Astrocyte/microglia cocultures as a model to study neuroinflammation. Methods Mol Biol. 2018;1727:127.
   PubMedGoogle Scholar
• Li L, Xu S, Liu L, et al. Multifunctional compound AD-35 improves cognitive impairment and attenuates the production of TNF-α and IL-1β in an Aβ25–35-induced Rat Model of Alzheimer’s disease. J Alzheimers Dis. 2017;56(4):1403.
   PubMed Web of Science ®Google Scholar
• McFarland AJ, Davey AK, McDermott CM, et al. Differences in statin associated neuroprotection corresponds with either decreased production of IL-1β or TNF-α in an, in vitro, model of neuroinflammation-induced neurodegeneration. Toxicol Appl Pharmacol. 2018;344:56–73.
   PubMed Web of Science ®Google Scholar
• Liu M, Li Y, Liang B, et al. Hydrogen sulfide attenuates myocardial fibrosis in diabetic rats through the JAK/STAT signaling pathway. Int J Mol Med. 2018;41(4):1867–1876.
   PubMed Web of Science ®Google Scholar
• Matsumoto J, Dohgu S, Takata F, et al. TNF-α-sensitive brain pericytes activate microglia by releasing IL-6 through cooperation between IκB-NFκB and JAK-STAT3 pathways. Brain Res. 2018;1692:34–44.
   PubMed Web of Science ®Google Scholar
• Jian M, Kwan J, Bunting M, et al. Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-kB signaling pathway. J Neuroinflammation. 2019;16(1):110.
   PubMedGoogle Scholar
• Park J, Min JS, Kim B, et al. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways. Neurosci Lett. 2015;584:191–196.
   PubMed Web of Science ®Google Scholar
• Priyadarshini L, Aggarwal A. Astaxanthin inhibits cytokines production and inflammatory gene expression by suppressing IκB kinase-dependent nuclear factor κB activation in pre and postpartum Murrah buffaloes during different seasons. Vet World. 2018;11(6):782–788.
   PubMed Web of Science ®Google Scholar
• Rhodus NL, Cheng B, Myers S, et al. The feasibility of monitoring NF‐κB associated cytokines: TNF‐α, IL‐1α, IL‐6, and IL‐8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog. 2005;44(2):77–82.
   PubMed Web of Science ®Google Scholar
• Lujan DA, Ochoa JL, Hartley RS. Cold-inducible RNA binding protein in cancer and inflammation. Wiley Interdiscip Rev RNA. 2018;9(2):e1462.
   Web of Science ®Google Scholar
• Kim KN, Heo SJ, Yoon WJ, et al. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. Eur J Pharmacol. 2010;649(1–3):369–375.
   PubMed Web of Science ®Google Scholar
• Chen S, Ren Z, Yu D, et al. DNA damage‐induced apoptosis and mitogen‐activated protein kinase pathway contribute to the toxicity of dronedarone in hepatic cells. Environ Mol Mutagen. 2018;59(4):278–289.
   PubMed Web of Science ®Google Scholar
• Win S, Than TA, Zhang J, et al. New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases. Hepatology. 2018;67(5):2013–2024.
   PubMed Web of Science ®Google Scholar
• Pyo H, Jou I, Jung S, et al. Mitogen-activated protein kinases activated by lipopolysaccharide and β-amyloid in cultured rat microglia. NeuroReport. 1998;9(5):871–874.
   PubMed Web of Science ®Google Scholar
• Lim JY, Won TJ, Hwang BY, et al. The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways. Eur J Pharmacol. 2010;642(1–3):10–18.
   PubMed Web of Science ®Google Scholar
• Svensson C, Part K, Künnis-Beres K, et al. Pro-survival effects of JNK and p38 MAPK pathways in LPS-induced activation of BV-2 cells. Biochem Biophys Res Commun. 2011;406(3):488–492.
   PubMed Web of Science ®Google Scholar
• Dan F, Ling W-H, Duan R-D. Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-κB in macrophages. Inflammation Res. 2010;59(2):115–121.
   PubMed Web of Science ®Google Scholar
• Gan P, Zhang L, Chen Y, et al. Anti-inflammatory effects of glaucocalyxin B in microglia cells. J Pharmacol Sci. 2015;128(1):35–46.
   PubMed Web of Science ®Google Scholar
• Fouad AA, Abdel-Aziz AM, Hamouda A. Diacerein downregulates NLRP3/Caspase-1/IL-1βand IL-6/STAT3 pathways of inflammation and apoptosis in a Rat Model of Cadmium Testicular Toxicity. Biol Trace Elem Res. 2020;195(2):499–505.
   PubMed Web of Science ®Google Scholar
• Dieteren S, Franz N, Khler K, et al. Ethyl pyruvate reduces systemic leukocyte activation via caspase-1 and NF-κB after blunt chest trauma and haemorrhagic shock. Front Med (Lausanne). 2020;7:562904.
   PubMed Web of Science ®Google Scholar
• Baroja-Mazo A, Compan V, Martín-Sánchez F, et al. Early endosome autoantigen 1 regulates IL-1βrelease upon caspase-1 activation independently of gasdermin D membrane permeabilization[J]. Sci Rep. 2019;9(1):5788.
   PubMedGoogle Scholar
• Wang XD, Ye T, Jin C, et al. Preliminary study on serum pharmacochemistry of tripterygium glycosides heptotoxicity. Mod Chin Med. 2017;19(3):362–371.
   Google Scholar
• Feng Q, Luan YF, Sun R. Research development on toxicity of Tripterygium wilfordii related to efficacy and chemical material basis. Chin J Pharmacovigilance. 2013;10(2):88–92.
   Google Scholar
• Wang J, Miao M, Qu L, et al. Protective effects of geniposide against Tripterygium glycosides (TG)-induced liver injury and its mechanisms. J Toxicol Sci. 2016;41(1):165–173.
   PubMed Web of Science ®Google Scholar
• Wang J, Miao M, Zhang Y, et al. Quercetin ameliorates liver injury induced with Tripterygium glycosides by reducing oxidative stress and inflammation. Can J Physiol Pharmacol. 2015;93(6):427–433.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu J, Cui Y, et al. Hepatoprotective effects of Lysimachia christinae hance extracts on acute liver injury induced by Tripterygium glycosides in mice. Chin Pharm J. 2013;1:30–34.
   Google Scholar
• Zhou YL, Zhang L, Liu X. Protective effect of total glucosides of paeony against acute hepatic injury induced by tripterygium glycosides tablet in mice. Tianjin J Traditional Chin Med. 2007;24(1):61–62.
   Google Scholar
• Cao S, Lu BP, Hu DH. Effect of total Saponins from Tribulus Terrestris on caspase-3 expression of liver tissues in mice with acute liver injury induced by tripterygium glycosides. China J Chin Med. 2011;26(8):951–953.
   Google Scholar